Login

Financial Snapshot

Revenue
TTM
$28.86M
Gross Margin
TTM
42.23%
Net Income
TTM
-$7.097M
Current Assets
2025 Q4
$11.89M
Current Liabilities
2025 Q4
$11.61M
Current Ratio
2025 Q4
102.36%
Total Assets
Total Liabilities
Book Value
2025 Q4
12.91M cads
Cash
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$1.102M

Stock Price

Loading...
Market Cap: $11.584 Million

About Medicure Inc

Medicure, Inc. is a pharmaceutical company, which engages in the research, clinical development, and commercialization of cardiovascular therapeutics. The company is headquartered in Winnipeg, Manitoba and currently employs 22 full-time employees. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. The company operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. The company operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. The company develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.

Industry: Pharmaceutical Preparations Peers: Sunshine Biopharma Inc Xenon Pharmaceuticals Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support